To Analyze the Influencing Factors of Postoperative Pathological Staging Upgrade in Patients with Non-small Cell Lung Cancer
Objective:To analyze the influencing factors of postoperative pathological staging and upgrading in patients with non-small cell lung cancer Methods:From May 2022 to May 2023,124 cases of non-small cell lung cancer were ana-lyzed retrospectively.The general clinical data of patients were collected,and they were divided into non-escalation group(n=72)and escalation group(n=52)according to whether pathological staging occurred after operation.Multiple linear regression method was used to analyze the risk factors affecting the postoperative pathological staging and upgrading.Re-sults:Univariate analysis showed that the age、the way of finding、the diameter of tumor、postoperative adjuvant chemother-apy and postoperative risk factors were compared between the upgraded group and the non-upgraded group(P<0.05).Multivariate analysis showed that age≥60 years、no postoperative adjuvant chemotherapy and postoperative risk factor score≥2 were the risk factors for postoperative pathological staging and upgrading of patients with non-small cell lung cancer(P<0.05).The 6-month and 12-month survival rates of the non-upgraded group were higher than those of the upgraded group(P<0.05).Conclusion:There are many factors influencing postoperative pathological escalation in patients with non-small cell disease.Elderly patients,patients without postoperative adjuvant chemotherapy and patients with postoperative risk factors score≥2 are at higher risk of postoperative pathological escalation,which needs to be paid great attention to in clinic and corresponding intervention measures should be taken as soon as possible.
Non-small cell lung cancerPostoperative adjuvant chemotherapyPathological staging and upgrading
国家科技期刊平台
NSTL
万方数据
